Leptin decreases appetite and increases sympathetic nerve activity and arte
rial pressure. Recent reports suggest that leptin may also have peripheral
vasodilator actions that would tend to reduce arterial pressure. We tested
the hypothesis that the direct vascular actions of leptin oppose sympatheti
cally mediated vasoconstriction. We evaluated the effects of intravenous le
ptin (1 mg/kg over 3 hours) on arterial pressure and mesenteric, hindlimb,
and renal blood flows in conscious rats. We then tested whether blockade of
nitric oxide or the sympathetic nervous system would unmask a pressor or d
epressor effect of leptin, consistent with direct vascular actions. Acute i
ntravenous administration of leptin alone did not change arterial pressure
or regional blood flows. This was despite a significant increase in lumbar
sympathetic nerve activity. Administration of the nitric oxide synthase inh
ibitor NG-nitro-L-arginine methyl ester significantly increased arterial pr
essure and caused vasoconstriction. However, leptin did not have any signif
icant effect on hemodynamics in the presence of N-G-nitro-L-arginine methyl
ester despite continued sympathoactivation. a-Adrenoceptor blockade with p
razosin alone or combined with yohimbine significantly decreased arterial p
ressure and caused vasodilation. Again, leptin did not have any effect on a
rterial pressure or regional blood flow in the presence of sympathetic bloc
kade. These data demonstrate that leptin does not have vasodilator actions
in vivo at concentrations that are sufficient to increase sympathetic nerve
activity. The absence of a pressor effect of leptin-induced sympathetic ac
tivation may merely reflect the brief duration of leptin administration. Th
ese data support the concept that the chronic hemodynamic actions of leptin
are likely to be related to sympathetic activation.